A 0 1 0 1 O
pregnancy 2 11 2 11 B-pregnancy
test 12 16 12 16 O
will 17 21 17 21 O
be 22 24 22 24 O
conducted 25 34 25 34 O
at 35 37 35 37 O
both 38 42 38 42 O
visits 43 49 43 49 O
prior 50 55 50 55 O
to 56 58 56 58 O
drug 59 63 59 63 O
administration 64 78 64 78 O
. 78 79 78 79 O
Uterine 80 87 80 87 O
contractions 88 100 88 100 O
may 101 104 101 104 O
occur 105 110 105 110 O
in 111 113 111 113 O
women 114 119 114 119 B-gender
and 120 123 120 123 O
are 124 127 124 127 O
more 128 132 128 132 O
likely 133 139 133 139 O
to 140 142 140 142 O
occur 143 148 143 148 O
in 149 151 149 151 O
pregnant 152 160 152 160 B-pregnancy
women 161 166 161 166 O
, 166 167 166 167 O
especially 168 178 168 178 O
towards 179 186 179 186 O
the 187 190 187 190 O
end 191 194 191 194 O
of 195 197 195 197 O
pregnancy 198 207 198 207 O

All 0 3 208 211 O
female 4 10 212 218 B-gender
subjects 11 19 219 227 I-gender
of 20 22 228 230 O
childbearing 23 35 231 243 O
capacity 36 44 244 252 O
will 45 49 253 257 O
have 50 54 258 262 O
a 55 56 263 264 O
urine 57 62 265 270 B-pregnancy
pregnancy 63 72 271 280 I-pregnancy
test 73 77 281 285 O
( 78 79 286 287 O
a 79 80 287 288 O
positive 81 89 289 297 O
test 90 94 298 302 O
will 95 99 303 307 O
exclude 100 107 308 315 O
the 108 111 316 319 O
subject 112 119 320 327 O
from 120 124 328 332 O
participation 125 138 333 346 O
) 138 139 346 347 O

All 0 3 348 351 O
subjects 4 12 352 360 O
will 13 17 361 365 O
have 18 22 366 370 O
a 23 24 371 372 O
diagnosis 25 34 373 382 O
of 35 37 383 385 O
autistic 38 46 386 394 B-chronic_disease
disorder 47 55 395 403 I-chronic_disease
or 56 58 404 406 O
ASD 59 62 407 410 B-chronic_disease
that 63 67 411 415 O
was 68 71 416 419 O
confirmed 72 81 420 429 O
by 82 84 430 432 O
administration 85 99 433 447 O
of 100 102 448 450 O
the 103 106 451 454 O
Autism 107 113 455 461 O
Diagnostic 114 124 462 472 O
Observation 125 136 473 484 O
Schedule 137 145 485 493 O
- 145 146 493 494 O
WPS 146 149 494 497 O
( 150 151 498 499 O
ADOS 151 155 499 503 O
- 155 156 503 504 O
WPS 156 159 504 507 O
) 159 160 507 508 O
( 161 162 509 510 O
30 162 164 510 512 O
) 164 165 512 513 O

Although 0 8 514 522 O
we 9 11 523 525 O
acknowledge 12 23 526 537 O
that 24 28 538 542 O
concomitant 29 40 543 554 O
medications 41 52 555 566 O
, 52 53 566 567 O
or 54 56 568 570 O
other 57 62 571 576 O
types 63 68 577 582 O
of 69 71 583 585 O
intervention 72 84 586 598 O
, 84 85 598 599 O
may 86 89 600 603 O
potentially 90 101 604 615 O
bias 102 106 616 620 O
study 107 112 621 626 O
results 113 120 627 634 O
, 120 121 634 635 O
participants 122 134 636 648 O
will 135 139 649 653 O
be 140 142 654 656 O
allowed 143 150 657 664 O
to 151 153 665 667 O
stay 154 158 668 672 O
on 159 161 673 675 O
concomitant 162 173 676 687 O
medications 174 185 688 699 O
and 186 189 700 703 O
non 190 193 704 707 B-treatment
- 193 194 707 708 I-treatment
pharmacologic 194 207 708 721 I-treatment
treatments 208 218 722 732 I-treatment
, 218 219 732 733 O
provided 220 228 734 742 O
that 229 233 743 747 O
no 234 236 748 750 O
changes 237 244 751 758 O
are 245 248 759 762 O
made 249 253 763 767 O
within 254 260 768 774 O
3 261 262 775 776 B-upper_bound
months 263 269 777 783 I-upper_bound
prior 270 275 784 789 I-upper_bound
to 276 278 790 792 O
baseline 279 287 793 801 O
and 288 291 802 805 O
that 292 296 806 810 O
no 297 299 811 813 O
changes 300 307 814 821 O
are 308 311 822 825 O
made 312 316 826 830 O
during 317 323 831 837 O
the 324 327 838 841 O
study 328 333 842 847 O

As 0 2 848 850 O
a 3 4 851 852 O
result 5 11 853 859 O
, 11 12 859 860 O
we 13 15 861 863 O
exclude 16 23 864 871 O
pregnant 24 32 872 880 B-pregnancy
female 33 39 881 887 B-gender
patients 40 48 888 896 I-gender
, 48 49 896 897 O
sexually 50 58 898 906 O
active 59 65 907 913 O
female 66 72 914 920 O
patients 73 81 921 929 O
on 82 84 930 932 O
hormonal 85 93 933 941 O
birth 94 99 942 947 O
control 100 107 948 955 O
and 108 111 956 959 O
sexually 112 120 960 968 O
active 121 127 969 975 O
females 128 135 976 983 B-gender
who 136 139 984 987 O
do 140 142 988 990 O
not 143 146 991 994 O
use 147 150 995 998 O
two 151 154 999 1002 O
types 155 160 1003 1008 O
of 161 163 1009 1011 O
non 164 167 1012 1015 O
- 167 168 1015 1016 O
hormonal 168 176 1016 1024 O
birth 177 182 1025 1030 O
control 183 190 1031 1038 O

Individuals 0 11 1039 1050 O
that 12 16 1051 1055 O
are 17 20 1056 1059 O
on 21 23 1060 1062 O
antipsychotic 24 37 1063 1076 B-treatment
drugs 38 43 1077 1082 I-treatment
will 44 48 1083 1087 O
be 49 51 1088 1090 O
excluded 52 60 1091 1099 O
from 61 65 1100 1104 O
participation 66 79 1105 1118 O
. 79 80 1118 1119 O
All 81 84 1120 1123 O
subjects 85 93 1124 1132 O
must 94 98 1133 1137 O
lack 99 103 1138 1142 O
a 104 105 1143 1144 O
significant 106 117 1145 1156 O
medical 118 125 1157 1164 O
history 126 133 1165 1172 O

Participants 0 12 1173 1185 O
will 13 17 1186 1190 O
be 18 20 1191 1193 O
between 21 28 1194 1201 O
5 29 30 1202 1203 B-lower_bound
and 31 34 1204 1207 O
40 35 37 1208 1210 B-upper_bound
years 38 43 1211 1216 I-upper_bound
of 44 46 1217 1219 O
age 47 50 1220 1223 B-age

This 0 4 1224 1228 O
includes 5 13 1229 1237 O
, 13 14 1237 1238 O
but 15 18 1239 1242 O
is 19 21 1243 1245 O
not 22 25 1246 1249 O
limited 26 33 1250 1257 O
to 34 36 1258 1260 O
impairment 37 47 1261 1271 O
of 48 50 1272 1274 O
renal 51 56 1275 1280 O
function 57 65 1281 1289 O
, 65 66 1289 1290 O
evidence 67 75 1291 1299 O
or 76 78 1300 1302 O
history 79 86 1303 1310 O
of 87 89 1311 1313 O
malignancy 90 100 1314 1324 B-cancer
or 101 103 1325 1327 O
any 104 107 1328 1331 O
significant 108 119 1332 1343 O
hematological 120 133 1344 1357 B-chronic_disease
, 133 134 1357 1358 O
endocrine 135 144 1359 1368 B-chronic_disease
, 144 145 1368 1369 O
respiratory 146 157 1370 1381 B-chronic_disease
, 157 158 1381 1382 O
hepatic 159 166 1383 1390 B-chronic_disease
, 166 167 1390 1391 O
cardiovascular 168 182 1392 1406 B-chronic_disease
or 183 185 1407 1409 O
gastrointestinal 186 202 1410 1426 B-chronic_disease
disease 203 210 1427 1434 I-chronic_disease

